Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FEI announces changes to Equine Prohibited Substances List
FEI Bureau has approved the changes proposed by the FEI List Group

The Fédération Equestre Internationale (FEI) Bureau has approved changes to the Equine Prohibited Substances List proposed by its List Group. The new prohibited substances list will come into effect on January 1, 2014.

Previously unlisted Metformin, a potent but legitimate oral anti-diabetic drug with a potential welfare risk, has been added to the Controlled Medication list.

Levothyroxine, an exogenous thyroid hormone replacement that could enhance performance, has also been added to the Controlled Medication list after having been unlisted.

Adrenocortico-trophic hormone (ACTH) will be moved from Banned Substances to the Controlled Medication section for the 2014 list, due to its therapeutic value in equine medicine.

Three previously unlisted substances will be added to the Banned Substances section of the 2014 list .

Ammonium Chloride injectable, Gamma Butyrolactone (GBL) and Gamma-Hydroxybutyrate (GHB) are considered to have the potential for abuse to improve athletic performance.

The approved changes to the list are also accessible on the FEI Clean Sport webpage.

The FEI Equine Prohibited Substances Database will be amended and the complete 2014 list will be made available on the Clean Sport website prior to January 1, 2014.

Conforming with FEI rules, all changes to the list are published 90 days prior to implementation to allow National Federations, athletes and veterinarians sufficient time to familiarise themselves with the revised list.

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.